Atlanta Perinatal Associates  |  Patient Education

Cystic Fibrosis
Carrier Consultation

A Guide for Your Pregnancy


C. Onyeije, MD  |  Maternal-Fetal Medicine


ACOG Guideline-Based Patient-Facing SMFM Endorsed
Understanding the Condition

What is Cystic Fibrosis?


🧬
Genetic
A permanent condition caused by changes in the CFTR gene.
💧
Mucus
Causes thick, sticky mucus that affects the lungs, pancreas, and other organs.
🧠
Not the Brain
CF does not affect intelligence or brain development.

CF affects approximately 1 in 2,500 Caucasian births and 1 in 2,300 Ashkenazi Jewish births.  ACOG

The Science

How CF Works: The CFTR Channel


The CFTR gene controls a protein channel that moves chloride ions in and out of cells.


When CFTR is abnormal, chloride ions are trapped inside cells, drawing water in and creating thick, sticky mucus on cell surfaces.


This mucus clogs the lungs, digestive tract, and other organs — causing the symptoms of CF.

CFTR Channel diagram showing normal vs abnormal function
Clinical Features

Symptoms of Cystic Fibrosis


🫁
Lungs
Chronic cough, repeated lung infections, difficulty breathing
🥗
Digestion
Poor weight gain, fatty stools, pancreatic insufficiency
💊
Treatment
New therapies have dramatically improved life expectancy and quality of life

Symptoms vary widely. People with CF attend school, hold careers, and live full, independent lives.

Your Status

You Are a Healthy Carrier


✅
One Working Gene
You have one normal CFTR gene that functions properly.
⚠️
One Changed Gene
You have one changed CFTR gene (mutation) that does not work normally.

Being a carrier does not mean you have cystic fibrosis.

Carriers are healthy and do not experience CF symptoms. Your pregnancy is not expected to be affected by your carrier status.

Genetics

How CF is Inherited


CF follows autosomal recessive inheritance. This means:


A child must receive a changed CFTR gene from both parents to have the disease.


If only one parent passes a changed gene, the child will be a healthy carrier — just like you.


The risk to your baby depends entirely on the carrier status of the baby's father.  ACOG

Each Pregnancy
50%
Normal gene
passed to child
50%
Changed gene
passed to child
Your contribution to each pregnancy
Inheritance Scenario 1

If Your Partner is Not a Carrier


≈ 0%
Risk of CF Disease
50%
Risk of Being a Carrier
50%
Risk of Neither
Inheritance diagram: one carrier parent, one non-carrier parent

If the father has two normal CFTR genes, your baby cannot have CF.

Inheritance Scenario 2

If Both Parents are Carriers


25%
Risk of CF Disease
50%
Risk of Being a Carrier
25%
Risk of Neither
Inheritance diagram: both parents are carriers

These probabilities apply to each pregnancy independently — they do not change based on previous pregnancies.

Risk Summary

Risk by Father's Carrier Status


Father's Status Risk: Child Has CF Risk: Child is a Carrier Risk: Child Unaffected
Not a Carrier ≈ 0% 50% 50%
Carrier (1 changed gene) 25% 50% 25%
Has CF (2 changed genes) 50% 50% 0%
Unknown Status Depends on ethnicity — —

Source: ACOG FAQ 171  |  Autosomal recessive inheritance principles

Immediate Action

The Most Important Next Step


Carrier screening for the baby's father

This is a simple blood or saliva test. It is the standard of care recommended by ACOG for all pregnancies where one parent is a known CF carrier.

🧪
Standard Panel
Tests for the 23 most common CFTR mutations (ACMG/ACOG recommended panel)
🔬
Expanded Panel
Tests for hundreds of rarer mutations; may be offered based on ethnicity or clinical concern
🧬
Full Sequencing
Complete CFTR gene analysis; highest sensitivity; used when high suspicion remains
Understanding Test Results

What Does a "Negative" Test Mean?


Negative Result

The father is very unlikely to be a CF carrier. The risk to your baby is greatly reduced.

Residual Risk

No test detects every possible rare mutation. A small "residual risk" remains even after a negative result. This risk varies by ethnicity.

Ethnicity Detection Rate Residual Risk*
Ashkenazi Jewish~94%Low
Caucasian / European~88–90%Low
Hispanic~72%Moderate
African American~64%Moderate
Asian American~49%Higher

*After a negative standard panel result.  ACOG CO 691

If Both Parents Are Carriers

Your Prenatal Diagnosis Options


If both you and your partner are confirmed CF carriers, you have the option of definitive prenatal testing to determine your baby's genetic status.


🩸
CVS
10–13 weeks
Placental tissue sample
Earlier results
Small risk of pregnancy loss
💉
Amniocentesis
After 15 weeks
Amniotic fluid sample
Highly accurate
Small risk of pregnancy loss
🔬
PGT-M (IVF)
Future pregnancies
Embryo testing before transfer
Selects unaffected embryos
Requires IVF

These are options, not requirements. The decision is yours. We will support whatever choice you make.  ACOG

Prenatal Diagnosis Option 1

Chorionic Villus Sampling (CVS)


Timing
Performed between 10 and 13 weeks of pregnancy
Procedure
A thin catheter is guided through the cervix or a needle through the abdomen to sample a small piece of placental tissue (chorionic villi)
Advantage
Provides the earliest possible diagnosis — results available in the first trimester
Risk
Small risk of pregnancy loss (~0.5–1%). We will discuss this fully before any procedure.
Chorionic Villus Sampling procedure diagram
Prenatal Diagnosis Option 2

Amniocentesis


Timing
Performed after 15 weeks of pregnancy (typically 15–20 weeks)
Procedure
A thin needle is guided through the abdomen using ultrasound to collect a small sample of amniotic fluid containing fetal cells
Accuracy
Provides a definitive diagnosis of the baby's CF gene status with high accuracy
Risk
Small risk of pregnancy loss (~0.1–0.3%). We will discuss this fully before any procedure.
Amniocentesis procedure diagram
Ultrasound Monitoring

What We Watch for on Ultrasound


Echogenic Bowel

The fetal bowel appears brighter than normal on ultrasound. This is a soft marker — it can be associated with CF, but is not a diagnosis.

What It Means

If echogenic bowel is seen, we may recommend CF carrier testing for the father (if not already done), or discuss amniocentesis for definitive diagnosis.

Fetal ultrasound showing abdominal anatomy with liver, stomach, spleen labeled
If Prenatal Testing Confirms CF

If Your Baby Has CF: Hope and Planning


🏥
CF Center Referral
Early referral to a specialized CF Center allows for optimal preparation and care planning from birth
💊
HEMT Therapy
New Highly Effective Modulator Therapies (e.g., Trikafta) have transformed CF from a terminal illness to a manageable chronic condition
📈
Improved Outlook
Life expectancy has increased dramatically. Many people with CF now live into their 40s, 50s, and beyond

A diagnosis of CF is not what it once was. Modern therapies have fundamentally changed the trajectory of this disease.

After Delivery

Newborn Screening for CF


All babies born in the United States are screened for cystic fibrosis at birth as part of the standard newborn screening panel.


This screening is done regardless of whether prenatal testing was performed.

Step 1: IRT
Immunoreactive trypsinogen (IRT) level measured from a heel-stick blood sample
Step 2: DNA Analysis
If IRT is elevated, CFTR DNA analysis is performed to confirm or rule out CF
Early Diagnosis
Early identification allows treatment to begin before symptoms develop, improving long-term outcomes
Your Health

Your Health as a Carrier


✅
Pregnancy
Being a CF carrier is not expected to cause complications in your pregnancy
ℹ️
Emerging Data
Recent studies suggest carriers may have a slightly higher rate of chronic sinusitis or pancreatitis compared to the general population
👩‍⚕️
Your Doctor
Discuss any respiratory or digestive symptoms with your physician. Routine prenatal care continues as normal.

Carriers are healthy individuals. Your carrier status does not require any special treatment or monitoring during pregnancy.  ACOG

Your Action Plan

What Happens Next


Step 1 — Partner Testing Now
The baby's father undergoes CF carrier screening (blood or saliva test). This is the most important immediate step.
Step 2 — Review Results 1–2 Weeks
We review the father's results together. If negative, your baby's risk is very low. If positive, we discuss prenatal diagnosis options.
Step 3 — Prenatal Diagnosis (if needed) Optional
If both parents are carriers, CVS (10–13 weeks) or amniocentesis (after 15 weeks) can tell us the baby's exact genetic status.
Step 4 — Newborn Screening At Birth
All newborns are screened for CF at birth, regardless of prenatal testing results.
Atlanta Perinatal Associates

We Are Your Partners


Our goal is to give you clear, honest information and to support you at every step. You are not alone in this process.


📋
ACOG Guidelines
All recommendations follow ACOG and SMFM evidence-based guidelines
🤝
Your Choice
All testing and diagnostic decisions are yours. We provide information and support.
💬
Questions?
Please ask us anything. No question is too small. We are here for you.

References: ACOG FAQ 171 (2025)  |  ACOG Committee Opinion 691  |  SMFM Prenatal Genetic Screening Recommendations (2025)  |  ACMG/ACOG CF Carrier Screening Guidelines  |  Cystic Fibrosis Foundation